Photobiomodulation Ameliorates Alexander Disease Through AMPK / mTOR ‐Mediated Mitophagy
Glia · 2026
DOI: 10.1002/glia.70229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2026. Verfasst von Nianzhuang Qiu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, School of Basic Medical Sciences, National Institute on Drug Dependence, Peking University, Beijing, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Mitophagy, AMP-Activated Protein Kinases, Alexander Disease. Die Arbeit nennt 110 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Special Fund for Research on National Major Research Instruments of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Alexander disease (AxD) is a rare neurodegenerative disorder characterized by the pathological accumulation of Rosenthal fibers (RFs) and astrocytic inflammation. Despite advances in elucidating its genetic basis, effective therapeutic strategies remain limited. Recent studies indicate that astrocytes in AxD exhibit excessive mitochondrial fragmentation, which may cause mitochondrial dysfunction and inflammatory response. Photobiomodulation (PBM) has been shown to improve mitochondrial function and exert anti‐inflammatory effects, suggesting it may be a promising candidate for the treatment of AxD. Here, we report that exposure to 1070‐nm infrared light exerts therapeutic efficacy in AxD. Specifically, using the astrocytes derived from AxD patients and a mouse model of AxD, we demonstrate that PBM regulates AMPK/mTOR signaling and promotes mitophagy, thereby attenuating reactive oxygen species production from fragmented mitochondria and subsequent inflammatory status. This study suggests PBM may serve as a novel, non‐invasive therapeutic approach for the treatment of AxD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, School of Basic Medical Sciences, National Institute on Drug Dependence, Peking University, Beijing, China.
- Beijing Key Laboratory of Innovative Intervention Techniques and Translational Research for Mental Disorders Rehabilitation, Peking University, Beijing, China.
- Children's Medical Center, Department of Pediatric Neurology, Peking University First Hospital, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
- The Center of Biomedical Engineering, Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
- Institute of Medical Technology, Peking University Health Science Center, Beijing, China.
ORCID-Profile: Nianzhuang Qiu, Jie Zhang, Huan Yi, Shumin Gao, Jie Shi, Jia Jia Liu, Ye Wu, Xunbin Wei, Ya Bin Wei
Förderung
- National Key Research and Development Program of China
- Special Fund for Research on National Major Research Instruments of China
- National Natural Science Foundation of China
Zitieren
APA
Qiu, N., Zhang, J., Yi, H., Dong, S., Han, L., Feng, Z., Gao, S., Shi, J., Liu, J. J., Wu, Y., Wei, X., & Wei, Y. B. (2026). Photobiomodulation Ameliorates Alexander Disease Through AMPK / mTOR ‐Mediated Mitophagy. Glia. https://doi.org/10.1002/glia.70229
Vancouver
Qiu N, Zhang J, Yi H, Dong S, Han L, Feng Z, et al. Photobiomodulation Ameliorates Alexander Disease Through AMPK / mTOR ‐Mediated Mitophagy. Glia. 2026. doi:10.1002/glia.70229
BibTeX
@article{Qiu2026,
author = {Qiu, Nianzhuang and Zhang, Jie and Yi, Huan and Dong, Sihan and Han, Lei and Feng, Zhendong and Gao, Shumin and Shi, Jie and Liu, Jia Jia and Wu, Ye and Wei, Xunbin and Wei, Ya Bin},
title = {Photobiomodulation Ameliorates Alexander Disease Through AMPK / mTOR ‐Mediated Mitophagy},
journal = {Glia},
year = {2026},
doi = {10.1002/glia.70229}
}
EUVIMED